Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults. - Wikidata - awgldk - TriplyDB

Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

http://www.wikidata.org/entity/Q43843541

about

Safety of Levetiracetam in Paediatrics: A Systematic Review Epilepsy in India I: Epidemiology and public health Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology Estimating the Prevalence of Treated Epilepsy Using Administrative Health Data and Its Validity: ESSENCE Study.How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years.Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.A prospective study of adverse drug reactions to antiepileptic drugs in children.Estimating Epilepsy Incidence and Prevalence in the US Pediatric Population Using Nationwide Health Insurance Claims Data.Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.Sociodemographic disparities in administration of antiepileptic drugs to adults with epilepsy in Germany: a retrospective, database study of drug prescriptions.Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis.Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison.The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data.Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil.Auswirkungen der frühen Nutzenbewertung auf Patienten mit Epilepsie in Deutschland Gesundheitsökonomie und Lebensqualität bei Epilepsie Leitlinienumsetzung und Kosten bei neudiagnostizierter Epilepsie

P2860

Q26765160-5F7FC643-2426-4C01-A71B-960E7EC018E4 Q26783630-F296360C-2ABC-4DEB-80DF-62100E08F583 Q26785420-5A3737B9-2CA0-42F5-8574-130BD24E4CBC Q31106346-B9CACE76-ABB5-4FF1-82E4-ABB056264982 Q34315074-A5F6BF9C-3516-4A66-9A2A-6E96E0E8ED9A Q35684841-B8B9FA8A-E24F-4914-99B7-BD062D2F12E5 Q35691762-79745F86-4DA3-4D13-BE72-E6AD37BA0BE7 Q35882310-8F72BB84-A649-4903-8297-09C5095DE96A Q38236299-9FF95AC0-081D-44D9-A6A1-B057698DDA46 Q39605188-E0EEEF0E-251D-4653-83ED-ABC6DA512032 Q40206269-51410B36-41CC-457B-AD97-0B264120F168 Q40508546-8862B409-64A0-4F34-88C9-4E63303FE164 Q40667644-08EB7E47-9739-4321-A9C8-8EE91149FC9C Q40875239-70B8531E-8F3B-4014-91B4-5FE881AB5E85 Q45814535-FE057DAB-16F9-44EB-BE9D-025830E4F8E1 Q47194338-7DDBA913-442A-47F7-9E83-3EE1142D3542 Q53834454-1D7AA6B3-1844-4DC1-9591-955B9A0EA7B8 Q58594729-9583F01D-8195-46BA-88B0-3E90DC1381FF Q58594852-097DE8EC-D2AD-4BC4-98A7-F7F17B524639 Q58594866-806E3DD0-6D46-48EC-B81B-FEA201C8E767

P2860

Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

http://www.wikidata.org/entity/Q43843541

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Prevalence, utilization, and c ...... study in children and adults.

@en

Prevalence, utilization, and c ...... study in children and adults.

@nl

type

label

Prevalence, utilization, and c ...... study in children and adults.

@en

Prevalence, utilization, and c ...... study in children and adults.

@nl

prefLabel

Prevalence, utilization, and c ...... study in children and adults.

@en

Prevalence, utilization, and c ...... study in children and adults.

@nl

P1433

Q43843541-4625A0B4-2935-499E-AF71-9B93F77D5C24

P1476

Q43843541-E4381DAA-4E00-4A70-B844-1AFFFC1E9BA0

P2093

Q43843541-0AAF11D0-3C43-45CC-ABEA-9388D0DE3154

Q43843541-1CD66A0B-7874-4206-B4CA-F00886ACF7D9

Q43843541-257D6D17-6F4A-4C85-98AA-66A70CA34424

Q43843541-32BD0B48-C89A-4179-BB6B-E18919402395

Q43843541-5FBC0F9B-9C44-4A6E-9E6E-FE3CA59CE62E

Q43843541-894D89CA-AC4F-4ACD-AD92-5EC27CA07205

Q43843541-8DB5109B-5BD3-4D93-8709-824E4156AB9D

Q43843541-CDE15E8E-D028-4F7C-8416-915D813ACDDA

Q43843541-DDFBCFF5-E74D-43FF-928F-438B58AEACAF

P2860

Q43843541-0A50770D-B621-494D-9749-0384C25C483D

Q43843541-0DAEE65B-D39F-4ECB-B4D8-442ABE41D3E8

Q43843541-0DF4DBB6-A92F-42B9-9DA1-2C783F6C8EFB

Q43843541-1921ED73-34F9-4F13-ADC1-D99A6E76F3DC

Q43843541-36E0CEC1-B4F2-41DA-AB16-D0E1B3BECCC3

Q43843541-3AA48497-E6DE-474D-888B-D6ABC01C4D29

Q43843541-3F80BD2D-6A11-4674-8E3D-F2C153849210

Q43843541-4D02BB8C-E054-4C56-8033-49FC019F197D

Q43843541-52467FB6-107F-4292-9EB6-EFB1FEEA338B

Q43843541-5363A274-50CB-40C6-937C-E8D0E8130EFD

P2888

Q43843541-A28D1345-9FC9-40C2-9F31-DF76972B9B09

P304

Q43843541-A5A574FD-BA36-4FA7-B6D4-A4205D5D21A0

P31

Q43843541-9EBB87A6-DC64-4B19-B66E-9D433227B724

P356

Q43843541-B84EF451-B8FF-4802-B8FA-953BCB1ABAF4

P433

Q43843541-9A04CF6B-A80B-4B3D-88F0-2A84FB2F8CC8

P478

Q43843541-0928DF9D-C9B0-49FF-B854-C377071C4E7F

P50

Q43843541-6F8E28B9-580D-46DD-8C5C-CDC897B5AD6D

Q43843541-717A7283-9421-44CD-AABE-281CB06C2F49

Q43843541-76ABDC60-EFB8-4A8C-BE3A-A2CD72D31BBA

P577

Q43843541-285F3B73-A26D-41C2-9785-028EAE5E6EE6

P698

Q43843541-B9588B6F-23D5-4F15-A791-2281196D3581

P921

Q43843541-F1355F84-518C-419A-B825-1C5ECE5E31C1

P356

S00415-012-6509-3

P1433

Journal of Neurology

P1476

Prevalence, utilization, and c ...... study in children and adults.

@en

P2093

Felix Rosenow

http://www.w3.org/2001/XMLSchema#string

Hajo M Hamer

http://www.w3.org/2001/XMLSchema#string

Jens-Peter Reese

http://www.w3.org/2001/XMLSchema#string

Karel Kostev

http://www.w3.org/2001/XMLSchema#string

Oliver Schöffski

http://www.w3.org/2001/XMLSchema#string

Richard Dodel

http://www.w3.org/2001/XMLSchema#string

Stefan Schwab

http://www.w3.org/2001/XMLSchema#string

Susanne Knake

http://www.w3.org/2001/XMLSchema#string

Wolfgang Graf

http://www.w3.org/2001/XMLSchema#string

P2860

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries.

Developing a computer algorithm to identify epilepsy cases in managed care organizations.

Economic evidence in epilepsy: a review.

The epidemiology of epilepsy in Europe - a systematic review.

Antiepileptic drugs: generic versus branded treatments.

Current approaches to the use of generic antiepileptic drugs.

Cost of epilepsy: a systematic review.

P2888

s00415-012-6509-3

P304

2376-2384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-012-6509-3

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

259

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Adam Strzelczyk

Monika Balzer-Geldsetzer

P577

2012-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22544296

http://www.w3.org/2001/XMLSchema#string

P921